Cannabis Related Content

Here, Savage Cabbage Ltd argue for a legitimate Industry Framework when it comes to hemp & CBD

Savage Cabbage Ltd give insight into the UK CBD market, defining the differences in cannabinoid products and their roles in the industry.

States that oversaw the legalization of recreational cannabis linked to increased alcohol consumption that is largely driven by young adults and men.

Pointing to advancements in public health, the UK government can improve access to cannabis by altering its CBD reform.

Lewis Koski, Chief Strategy Officer of Metrc, charts how cannabis tracking technology can help global supply chain struggles.

Our mission is to create an environment where individuals can source premium quality health products, such as CW CBD Oil, with confidence.

Germany has made plans to legalise cannabis, which could create up to 27,000 new jobs and save around about 4.7 billion euros.

Senior Associate David Hardstaff and Partner John Binns of BCL Solicitors LLP, share their views on a blueprint for the UK Cannabis Industry.

Menopause symptoms, ranging from hot flashes to weight gain, can be eased with cannabis and CBD, research finds.

America is gripped by opioid addiction and a dangerous opioid epidemic - could CBD be a viable replacement?

Cannabis legislation is threatening to reduce pharmaceutical stock value by billions of dollars as more people are predicted to opt for weed over opioids.

Medical cannabis remains difficult to attain in healthcare under the British government, but it holds great promise for both NHS patients and the economy.

Countries all over the world are debating whether to legalise cannabis; but what really happens when the recreational drug is made legal?

Cannabidiol, more commonly known as CBD, may halve the severity of symptoms and impairment caused by chronic anxiety.

Cannabinoids with high THC-to-CBD ratios can help to improve moderate, short-term chronic pain band may be an alternative to opioids.

Emergency department attendance and instances requiring hospitalisations are 22% higher among cannabis users compared with those who do not.

Here, Savage Cabbage explain why their full-spectrum Cannabidiol (CBD) products are different to others on the market.

Dr Stephen Barnhill M.D from Apollon Formularies Plc discusses the potential for technology to upgrade personalised medicine for cannabis treatments.

Nick Morland, Tenacious Labs CEO, All-Party Parliamentary Group for CBD Products Secretariat, Jersey Cannabis Services Advisory Board Chair, writes about the UK Cannabis Industry – could this be the next Scottish Whisky?

Research finds that labels on weed often fail to adequately reflect products' chemical make-up and components of the weed strain.